scispace - formally typeset
D

David M. Reith

Researcher at University of Otago

Publications -  138
Citations -  2827

David M. Reith is an academic researcher from University of Otago. The author has contributed to research in topics: Population & Poison control. The author has an hindex of 28, co-authored 138 publications receiving 2592 citations. Previous affiliations of David M. Reith include Royal Children's Hospital & Dunedin Public Hospital.

Papers
More filters
Journal ArticleDOI

Measurement of tubular enzymuria facilitates early detection of acute renal impairment in the intensive care unit

TL;DR: Tubular enzymuria on admission to the ICU is useful in predicting ARF and the cheapness and wide availability of automated assays for gamma GT and AP suggests that estimation of these enzymes in random urine samples may be particularly useful for identifying patients at high risk of ARF.
Journal ArticleDOI

Relative Toxicity of Beta Blockers in Overdose

TL;DR: Propranolol should be avoided in patients at risk of self-poisoning and clinical features predictive of serious toxicity are identified, including a significant association between a QRS duration of > 100 ms and risk of seizures.
Journal ArticleDOI

Repeated self-poisoning: increasing severity of self-harm as a predictor of subsequent suicide.

TL;DR: Patients who have escalating severity of self-poisoning episodes are at high risk of completed suicide, according to a nested case–control study used to identify exposure variables and the National Death Index.
Journal ArticleDOI

Incidence, preventability, and impact of Adverse Drug Events (ADEs) and potential ADEs in hospitalized children in New Zealand: a prospective observational cohort study.

TL;DR: ADEs represent a considerable hazard for the pediatric inpatient population and ADEs represent a large cost imposition upon the healthcare sector, highlighting the importance of developing strategies to prevent and ameliorate ADEs.
Journal ArticleDOI

Identification of priorities for medication safety in neonatal intensive care.

TL;DR: Interventions to decrease medication-related adverse events in the NICU should aim to increase staff awareness of medication safety issues and focus on medication administration processes.